DOSSIER · 13F Holders · Q1 2026Healthcare · Biological Products, (No Diagnostic Substances)Defensive growthQuality
GILD

GILEAD SCIENCES INC

2,432 institutions still hold GILEAD SCIENCES INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 375558103·Biological Products, (No Diagnostic Substances)·2,432 13F holders·last filed Mar 31, 2026
Market cap
8.2%
vs prior quarter
13F value held
$93.3B
51.0% inst. owned
of float
Holders
2,432
-109 QoQ
filers reporting
Activity
+8 / −54
+828 added · −881 reduced
this quarter
Concentration
17.79%
BlackRock, Inc. #1
top holder share
AI Holders Summary · Q1 2026

GILD Q1 2026 institutional ownership is a $139.8B book across 2,233 holders. BlackRock is the largest holder at $16.6B (119.0M shares, -8.2%, -$1.5B). Vanguard Capital Management is second at $11.2B (80.7M shares, NEW after three-way split). FMR/Fidelity is third at $10.0B (71.9M shares, +37.6%, +$1.97B) -- the largest buyer. State Street is fourth at $8.3B (59.9M shares, -11.4%, -$949M). Capital World Investors is fifth at $5.8B (41.3M shares, -8.3%, -$491M). Vanguard total passive ~$17.2B across three entities. JPMorgan $4.6B (+63.9%, +$1.81B) -- second-largest buyer. Geode Capital $4.1B (+1.7%). Capital Research Global $3.8B (+22.1%, +$675M). Dodge & Cox $3.4B (-7.2%). Morgan Stanley $3.2B (-5.1%). Bank of America $2.8B (-13.1%). MassFinancial $909M (+229.5%). Northern Trust $1.9B (-9.5%). BNY Mellon $2.1B (-9.8%). Goldman Sachs $1.6B (+48.1%, +$527M). UBS AM $1.8B (+26.6%). Legal & General $1.5B (+3.5%). Invesco $2.2B (-8.2%). Wellington $1.9B (-12.5%). Fundsmith $1.0B (-30.2%). AllianceBernstein $2.1B (-8.2%). Amundi $1.5B (+31.6%). New: Vanguard three-way. Sellers: BlackRock -$1.5B, State Street -$949M, Capital World -$491M, Bank of America -$535M, Morgan Stanley -$361M, Invesco -$251M, BNY Mellon -$228M, Northern Trust -$201M, Wellington -$267M, Fundsmith -$266M, Dodge & Cox -$154M, AllianceBernstein -$138M. Buyers: Fidelity +$1.97B, JPMorgan +$1.81B, Goldman +$527M, Capital Research Global +$675M, UBS AM +$244M, MassFinancial +$641M, Amundi +$300M, Legal & General +$192M, Geode +$498M. The 75.50 whaleScore reflects AUM. Smart-money read: net-bullish. Fidelity +1.97B and JPMorgan +1.81B are the largest two buys in this dataset. Cautiously bullish on GILD.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
BlackRock, Inc.
CIK 0002012383
$16.6B119.0M0.29%Q1 2026
02
VANGUARD CAPITAL MANAGEMENT LLC
CIK 0002100119· Index
$11.2B80.7M0.28%Q1 2026
03
FMR LLC
CIK 0000315066
$10.0B71.9M0.53%Q1 2026
04
STATE STREET CORP
CIK 0000093751
$8.3B59.9M0.29%Q1 2026
05
Capital World Investors
CIK 0001422849
$5.8B41.3M0.78%Q1 2026
06
Vanguard Portfolio Management
CIK 0002100121· Index
$4.9B35.1M0.26%Q1 2026
07
JPMORGAN CHASE & CO
CIK 0000019617
$4.6B34.0M0.30%Q1 2026
08
GEODE CAPITAL MANAGEMENT, LLC
CIK 0001214717· Index
$4.1B29.7M0.26%Q1 2026
09
Capital Research Global Investors
CIK 0001422848
$3.8B27.1M0.59%Q1 2026
10
DODGE & COX
CIK 0000200217
$3.4B24.3M1.86%Q1 2026
11
MORGAN STANLEY
CIK 0000895421
$3.2B23.3M0.20%Q1 2026
12
BANK OF AMERICA CORP /DE/
CIK 0000070858
$2.8B20.0M0.20%Q1 2026
13
Invesco Ltd.
CIK 0000914208
$2.2B15.5M0.33%Q1 2026
14
Bank of New York Mellon Corp
CIK 0001390777
$2.1B15.1M0.39%Q1 2026
15
NORTHERN TRUST CORP
CIK 0000073124· Index
$1.9B13.8M0.25%Q1 2026
16
WELLINGTON MANAGEMENT GROUP LLP
CIK 0000902219
$1.9B13.5M0.35%Q1 2026
17
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
CIK 0000861177
$1.8B13.2M0.38%Q1 2026
18
GOLDMAN SACHS GROUP INC
CIK 0000886982
$1.6B11.5M0.18%Q1 2026
19
Amundi
CIK 0001330387
$1.5B10.5M0.40%Q1 2026
20
Legal & General Group Plc
CIK 0000764068
$1.5B10.5M0.34%Q1 2026
Page 1 of 122
2412 more holders available. Log in →